NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Anzen Industries

Anzen Industries

Private
LondonHealthcare & Life Scienceshttps://anzenindustries.com/

Last Round

Pre Seed

Jan 19, 2026

Total Funding Raised

$2.2M

Company Overview

Anzen Industries is a biotechnology company that develops a cell-free biomanufacturing platform using modular enzyme reactors to produce high-value chemicals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing, Clean Manufacturing, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

cell-free biomanufacturingbiomanufacturingsynthetic biologyAI-designed enzymesbiocatalysismodular reactorsbiochemical productionprotein engineeringdeeptechsustainable ingredientsbiotech startupenzyme engineeringbio-based chemicalslab-grown ingredientsprecision fermentation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anzen Industries Comparables

Compare Anzen Industries with similar companies based on industry and business-model similarity.

Anzen Industries comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FabricNano
82%
eXoZymes Inc.
77%
Zymtronix
77%

Anzen Industries Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJan 19, 2026

Key People

Founding team and executive leadership

Pedro Lovatt Garcia

Co-Founder & CTO

Founding Team

Anzen Industries Investors

Notable investors and investment history

Anzen Industries investors
InvestorRounds
Phoenix Court GroupPre Seed
LocalGlobePre Seed
The Creator FundPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 19, 2026

    Developing a cell-free biomanufacturing platform for high-value chemicals.

Anzen Industries Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Anzen Industries Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Anzen Industries's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range3
Year Founded2024
Last FundingJan 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.